SANTINI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 23.439
EU - Europa 11.671
AS - Asia 9.551
SA - Sud America 1.380
AF - Africa 176
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 40
Totale 46.317
Nazione #
US - Stati Uniti d'America 22.468
CN - Cina 4.393
RU - Federazione Russa 2.842
IT - Italia 2.646
SG - Singapore 2.459
BR - Brasile 1.145
DE - Germania 1.124
HK - Hong Kong 945
UA - Ucraina 926
PL - Polonia 887
CA - Canada 853
SE - Svezia 759
GB - Regno Unito 717
FR - Francia 547
FI - Finlandia 459
TR - Turchia 365
KR - Corea 349
VN - Vietnam 260
IE - Irlanda 207
IN - India 185
NL - Olanda 117
JP - Giappone 102
MX - Messico 84
ES - Italia 74
AR - Argentina 70
ZA - Sudafrica 69
BD - Bangladesh 65
IR - Iran 62
EU - Europa 59
UY - Uruguay 56
PK - Pakistan 55
BE - Belgio 54
CZ - Repubblica Ceca 47
CH - Svizzera 45
IQ - Iraq 43
PT - Portogallo 39
AM - Armenia 35
AT - Austria 34
AU - Australia 31
RO - Romania 30
LT - Lituania 29
ID - Indonesia 28
CL - Cile 27
EG - Egitto 27
TH - Thailandia 23
MY - Malesia 22
NG - Nigeria 22
TW - Taiwan 22
UZ - Uzbekistan 19
EC - Ecuador 17
IL - Israele 17
PE - Perù 17
AE - Emirati Arabi Uniti 16
CO - Colombia 15
HU - Ungheria 15
KE - Kenya 13
MA - Marocco 13
PY - Paraguay 13
AZ - Azerbaigian 12
VE - Venezuela 12
JO - Giordania 11
SA - Arabia Saudita 10
BG - Bulgaria 8
HR - Croazia 8
NP - Nepal 8
DZ - Algeria 7
JM - Giamaica 7
KG - Kirghizistan 7
LK - Sri Lanka 7
NZ - Nuova Zelanda 7
PA - Panama 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
GR - Grecia 6
RS - Serbia 6
TN - Tunisia 6
DK - Danimarca 5
HN - Honduras 5
LU - Lussemburgo 5
MK - Macedonia 5
PS - Palestinian Territory 5
SN - Senegal 5
AL - Albania 4
LB - Libano 4
NO - Norvegia 4
PH - Filippine 4
BY - Bielorussia 3
KZ - Kazakistan 3
OM - Oman 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BW - Botswana 2
CM - Camerun 2
DM - Dominica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
Totale 46.283
Città #
Jacksonville 2.159
Woodbridge 1.974
Fairfield 1.890
Ashburn 1.669
Chandler 1.265
Houston 1.179
Wilmington 989
Singapore 969
Boardman 945
Hong Kong 927
Ann Arbor 827
Seattle 815
Dearborn 757
Beijing 732
Nanjing 695
Cambridge 606
Toronto 576
Warsaw 518
Camerino 492
The Dalles 406
Los Angeles 400
San Mateo 351
Kraków 344
Seoul 327
Tongling 315
Princeton 309
Lawrence 306
Columbus 296
Istanbul 285
New York 267
Ogden 238
Nanchang 222
Dublin 203
Helsinki 200
Dallas 199
Bremen 193
Buffalo 189
Chicago 166
Moscow 164
London 161
Shenyang 155
Lachine 154
Milan 153
Kunming 149
Rome 132
Shanghai 131
Guangzhou 130
São Paulo 119
Jiaxing 111
Tianjin 100
Munich 97
San Diego 89
Hebei 87
Düsseldorf 85
Redwood City 76
Changsha 75
Tokyo 73
Hefei 71
Jinan 70
Ho Chi Minh City 68
Wuhan 60
Brooklyn 58
Hangzhou 57
Hanoi 56
Santa Clara 56
Montevideo 55
Montreal 49
Redondo Beach 49
Salt Lake City 49
Frankfurt am Main 48
Verona 46
Zhengzhou 46
Chennai 45
Philadelphia 45
Venezia 44
Dong Ket 43
Falls Church 43
Johannesburg 43
San Francisco 43
Atlanta 42
Brussels 42
Orange 41
Stockholm 41
Denver 40
Rio de Janeiro 40
Phoenix 39
Manchester 38
Jinhua 36
Boston 34
Mexico City 34
Belo Horizonte 33
Ancona 32
Elk Grove Village 32
Orem 31
Council Bluffs 29
Lanzhou 29
Norwalk 29
Tampa 29
Turku 29
Ningbo 28
Totale 29.313
Nome #
Additivi inorganici ritardanti di fiamma non alogenati: idrossido di magnesio naturale ed idrossido di alluminio prodotti per macinazione 617
Functionalized gold nanorods as drug carriers: a promising antiviral system 351
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 308
XLIII Congresso Nazionale di Chimica Inorganica 297
Novel metalloantimalarials: Transmission blocking effects of water soluble Cu(I), Ag(I) and Au(I) phosphane complexes on the murine malaria parasite Plasmodium berghei 284
Novel triazolium based 11th group NHCs: synthesis, characterization and cellular response mechanisms 282
The hydridotris(3-nitro-1,2,4-triazol-1-yl)borate, a new nitro-substituted electron withdrawing polydentate "scorpionate"-type ligand and related copper and silver phosphane complexes 263
Chemistry and relevant biomimetic applications of group 6 metals systems supported by scorpionates 262
Boron-Centered Scorpionate-Type NHC-Based Ligands and Their Metal Complexes 254
null 248
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part A: pyrazole-based systems 248
Insights into the cytotoxic activity of the phosphane copper(I) complex [Cu(thp)4][PF6] 246
Copper(I) isocyanide and phosphane complexes of fluorinated mono- and bis-(pyrazolyl)borates 242
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 240
Syntheses and Biological Studies of Cu(II) Complexes Bearing Bis(pyrazol-1-yl)- and Bis(triazol-1-yl)-acetato Heteroscorpionate Ligands 230
Scorpionate complexes with the main group elements Ca, Ba, Sr 229
Electrospray ionization multi-stage mass spectrometric study of the interaction products of the cytotoxic complex [Cu(thp)4][PF6] with methionine-rich model peptides 223
Advances in Copper Complexes as Anticancer Agents 220
A new ester substituted heteroscorpionate ligand 219
Synthesis and properties of poly(pyrazolyl)borate and related boron-centered scorpionate ligands. Part B: imidazole-, triazole- and other heterocycle-based systems 218
Scorpionates bearing nitro substituents: mono-, bis- and tris-(3-nitro-pyrazol-1-yl)borate ligands and their copper(I) complexes 217
Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies 217
Synthesis, in vitro and in vivo characterization of Cu-64(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands 216
Copper(I)-organophosphine complexes of bis(3,5-dimethylpyrazol-1-yl) dithioacetate ligand 214
A Study on the Coordinative Versatility of new N,S-donor Macrocyclic Ligands: XAFS, and Cu2+ complexation thermodynamics in solution 210
Solution and solid-state structural properties of silver(I) dihydrobis(pyrazolyl)borate compounds with tertiary mono(phosphine) ligands 208
Oxo-rhenium(V) compounds containing bis(3,5-dimethylpyrazol-1-yl)acetate scorpionate ligand 204
Dalle fosfine ai carbeni idrosolubili: sviluppo di complessi del gruppo 11 e studi bioinorganici 200
Highly Hydrophilic Gold Nanoparticles as Carrier for Anticancer Copper(I) Complexes: Loading and Release Studies for Biomedical Applications 200
Silver(I) and copper(I) complexes supported by fully fluorinated 1,3,5-triazapentadienyl ligands 199
Silver(I) and gold(I) complexes of hydrotris(3,5-dimethylpyrazol-1-yl)borate: synthesis, spectroscopic and structural characterization, and reactivity toward C-, N- and S-donor ligands 199
In Vitro Antitumour Activity of Water Soluble Cu(I), Ag(I) and Au(I) Complexes Supported by Hydrophilic Alkyl Phosphine Ligands 199
Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes 199
11th workshop on PharmacoBioMetallics (BIOMET11) 198
Trinuclear copper(I) complexes with triscarbene ligands: catalysis of C-N and C-C coupling reactions 196
Synthesis, spectroscopic characterization, and structural systematics of new triorganophosphinecopper(I) poly(pyrazol-1-yl)borate complexes 195
New volatile polyazolylborates of copper(I) for MOCVD 194
Novel multicharged silver(I)–NHC complexes derived from zwitterionic 1,3-symmetrically and 1,3-unsymmetrically substituted imidazoles and benzimidazoles: Synthesis and cytotoxic properties 194
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 193
Bridged poly(1-imidazolyl)borate silver(I) complexes containing tertiary mono(phosphine) ligands. The first structurally authenticated bis(imidazolyl)borate metal complex 192
Synthesis and in vitro antitumor activity of water soluble sulfonate- and ester-functionalized silver(I) N-heterocyclic carbene complexes 192
[M(HB(pz)3)(P)] complexes (P = monodentate phosphine): comparison of the antiproliferative activity of silver and copper “3+1” mixed-ligand compounds 192
3rd INTERNATIONAL SCHOOL OF ORGANOMETALLIC CHEMISTRY “LIGANDS IN ORGANOMETALLIC CHEMISTRY: TRADITION AND INNOVATION” 191
Polypyrazolylborate and Scorpionate Ligands 190
Synthesis, characterization and crystal structure of new copper(II) complexes with tris- and tetrakis-(pyrazol-1-yl)borate ligands 190
Neutral and charged phosphine/scorpionate copper(I) complexes: Effects of ligand assembly on their antiproliferative activity 189
Variable co-ordination numbers in 1:1 adducts of silver(I) tetrakis(pyrazolyl)borates with tertiary phosphines 188
In vitro activity and neurotoxicity of new promising metal-based anticancer complexes 188
In vitro antitumor activity of the water soluble copper(I) complexes bearing tris(hydroxymethyl)phosphine ligand 187
Synthesis and spectroscopic characterization of new triorganotin(IV) complexes with the bis(1-methyl-1H-imidazol-2-ylthio)acetate ligand: effects on trout erythrocyte components 187
National Science Centre (NCN) of Poland. OPUS 12: general grants. 186
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 185
Synthesis, characterization and antioxidant activity of new copper(I) complexes of scorpionate and water soluble phosphane ligands 185
Silver(I) poly(1,2,3-benzotriazolyl)borate complexes containing mono- and bidentate phosphine coligands 185
Copper and Silver Derivatives of Scorpionates and related Ligands 185
FWF Austrian Science Fund (Stand-Alone Projects) 185
Synthesis and spectroscopic characterization of new organotin(IV) complexes with bis(3,5-dimethylpyrazol-1-yl)dithioacetate 184
Novel scorpionate-type triscarbene ligands and their silver and gold complexes 183
Biomimetic Applications of Metal Systems Supported by Scorpionates 183
Synthesis and solution studies by electrospray mass spectroscopy of new bis(imidazolyl)borate organotin(IV) complexes 182
The relationship between electrospray ionization behavior and cytotoxic activity of [MI(P)4]+-type complexes (M = Cu, Ag and Au; P = tertiary phosphine) 182
Trichloro-, mono-, di- and tri-organotin(IV) derivatives of hydridotris(4-methylpyrazol-1-yl)borates. 181
null 181
ACS Petroleum Research Fund Grant Programs - USA 181
Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand 180
Realizzazione del sito web e webmaster del XLIII Congresso Nazionale di Chimica Inorganica 180
B - The Romanian National Council for Scientific Research (CNCS) though Executive Agency for Higher Education, Research, Development and Innovation Funding, (UEFISCDI). PNCDI III - Programme 2 - Subprogramme 2.1. Competitiveness by research, development and innovation. Experimental Demonstrative Projects (PED 2016). 180
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 180
New (diphenylphosphane)benzoic acid copper(I) derivatives of “scorpionate” ligands with superoxide scavenging activity 178
Structure and volatility of copper complexes containing pyrazolyl-based ligands 178
Standard projects of the Czech Science Foundation (in Czech “Grantová agentura České republiky – GACR”) or Czech Health Research Council (in Czech “Agentura pro zdravotnický výzkum České republiky – AZV”) established by Ministry of Health of the Czech Republic. 178
C - The Romanian National Council for Scientific Research (CNCS) though Executive Agency for Higher Education, Research, Development and Innovation Funding, (UEFISCDI). PNCDI III - Programme 2 - Subprogramme 2.1. Competitiveness by research, development and innovation. Experimental Demonstrative Projects (PED 2016). 178
The reactivity of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate (Tm) towards organotin(IV) acceptors. An unprecedented monodentate coordination mode of Tm ligand 177
[Cu(thp)4][PF6] as an Effective Therapeutic Agent for the Treatment of Solid Tumors, including Refractory Tumors 176
Synthesis, characterization and hydrolytic behavior of new bis(2-pyridylthio)acetate ligand and related organotin(IV) complexes 176
Atti del Congresso XLIII Congresso Nazionale di Chimica Inorganica 176
New homoleptic carbene transfer ligands and related coinage metal complexes 175
Applications of scorpionate ligands in enzyme modeling and biological studies 175
Complessi di rame(I) con leganti tris(azolil)borati e fosfine monodentate: sintesi e studi biologici 175
Unsymmetrical 3- and 5-substituted bis(pyrazolyl)borate system 174
Di- and tri-organotin(IV) complexes of the new bis(1-methyl-1H-imidazol-2-ylthio) acetate ligand and the decarboxylated analogues 174
Development of new and efficient copper(II) complexes of hexyl bis(pyrazolyl)acetate ligands as catalysts for allylic oxidation 174
Synthesis and characterization of new organotin(IV) complexes with polyfunctional ligands 173
Synthesis and structural studies of a 1 : 2 adduct of silver(I) tetrakis(pyrazolyl)borate(III) with a tertiary phosphine 173
Copper in Diseases and Treatments, and Copper-based Anticancer Strategies 173
Synthesis, structural and spectroscopic characterization of new silver(I) poly(pyrazolyl)borate complexes containing isonitrile ligands 172
New phosphino silver(I) derivatives of hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. X-ray crystal structure of tricyclohexylphosphine-silver(I)-hydrotris(3-methyl-2-thioxo-1-imidazolyl)borate. 172
Tris(4-bromo-1H-pyrazol-1-yl)borato derivatives of first-row transition and group 12 and 14 metals. X-ray crystal structure of [HB(4-Brpz)3]2Cd. 113Cd solution NMR study of bis[poly(pyrazolyl)borato]cadmium complexes 171
[Cu(thp)4][PF6] as an effective therapeutic agent for the treatment of solid tumors, including refractory tumors 171
[Cu(thp)4]n[X]-n Compounds for the Treatment of a Broad Range of Human Solid Tumors, Including Refractory Tumors 170
XAFS studies on copper(I) complexes containing scorpionate ligands 169
Metal systems supported by Scorpionates 169
[Cu(thp)4][X] compounds for the treatment of a broad range of human solid tumors, including refractory tumors 169
Synthesis and characterization of new copper(I) complexes containing 4-(diphenylphosphane)benzoic acid and "scorpionate" ligands with "in vitro" superoxide scavenging activity 168
Coordination chemistry of the sterically hindered N3-donor hydrotris (3,5-diphenylpyrazol-1-yl) borate toward silver(I) triorganophosphino compounds. Synthesis, structural and spectroscopic characterization 168
Rational design and biological evaluation of novel conjugated heteroscorpionate ligands and related Copper(I/II) complexes 168
Front Cover, European Journal of Medicinal, Issue 146, 25 February 2018. 168
Synthesis and Biological Activity of Ester- and Amide-Functionalized Imidazolium Salts and Related Water-Soluble Coinage Metal N-Heterocyclic Carbene Complexes 168
Synthesis and SAR of symmetrical and non-symmetrical 11th group-NHC complexes 167
New N,N,O,O functionalized heteroscorpionate ligands and related Zn(II) and Cd(II) derivatives 166
Totale 20.226
Categoria #
all - tutte 204.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 204.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.293 0 0 0 0 0 364 692 114 498 157 954 514
2021/20223.139 276 853 59 88 233 128 106 250 234 326 246 340
2022/20233.837 364 48 117 538 536 558 19 253 782 194 285 143
2023/20243.345 475 178 287 106 172 334 121 191 393 99 86 903
2024/202510.190 404 246 963 578 379 501 967 2.326 768 777 794 1.487
2025/20266.451 866 890 1.058 1.963 1.488 186 0 0 0 0 0 0
Totale 47.202